Clinical Trials Logo

Clinical Trial Summary

Modulation of brain blood flow using dichoptic Visual and Auditory stimulation using REVIVIEW system will be evaluated.


Clinical Trial Description

The participant will undergo baseline MRI to measure blood flow in the brain for comparison later on. After baseline MRI, the participant will observe stimulation using the REVIVIEW system for 20 minutes. The content the participants will see is a nature documentary, after which the participant will undergo additional MRI imaging to assess the change in blood flow in the brain. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03632564
Study type Interventional
Source Visior Technologies Ltd.
Contact Arie Orenstain, Prof.
Phone 972-3-5302993
Email Arie.Orenstain@sheba.health.gov.il
Status Not yet recruiting
Phase N/A
Start date October 10, 2018
Completion date August 15, 2019

See also
  Status Clinical Trial Phase
Completed NCT01012674 - Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Phase 3
Completed NCT01010932 - Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Phase 3
Recruiting NCT06067113 - Hemodynamic and Functional Characteristics of the Cerebral Circulation in Obesity
Completed NCT04364074 - Acute Probiotic Supplementation and Endothelial Function N/A
Recruiting NCT02914288 - Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI N/A
Recruiting NCT04265053 - Human Cerebral Blood Flow Regulation Early Phase 1